Verrica Pharmaceuticals Inc. SEC filings VRCA
Verrica Pharmaceuticals Inc. has 534 filings in SEC EDGAR's recent list, going back to Dec 17, 2015. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 12, 2026 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 15, 2025 | — |
| S-8 | Employee stock plan registration | May 13, 2025 | — |
| S-3 | Shelf registration | Mar 11, 2025 | — |
| S-8 | Employee stock plan registration | Dec 9, 2024 | — |
| 424B5 | Prospectus supplement | Nov 21, 2024 | — |
| 424B5 | Prospectus supplement | Nov 20, 2024 | — |
| S-8 | Employee stock plan registration | Nov 6, 2024 | — |
| S-8 | Employee stock plan registration | May 13, 2024 | — |
| S-8 | Employee stock plan registration | May 9, 2023 | — |
| 424B5 | Prospectus supplement | Feb 22, 2023 | — |
| FWP | Free writing prospectus | Feb 21, 2023 | — |
| 424B5 | Prospectus supplement | Dec 19, 2022 | — |
| S-3 | Shelf registration | Nov 7, 2022 | — |
| 424B5 | Prospectus supplement | Jul 1, 2022 | — |
| 424B5 | Prospectus supplement | Jun 29, 2022 | — |
| S-8 | Employee stock plan registration | May 9, 2022 | — |
| S-8 | Employee stock plan registration | May 7, 2021 | — |
| 424B5 | Prospectus supplement | Mar 23, 2021 | — |
| 424B5 | Prospectus supplement | Mar 22, 2021 | — |
| S-8 | Employee stock plan registration | Mar 13, 2020 | — |
| S-3 | Shelf registration | Mar 13, 2020 | — |
| S-8 | Employee stock plan registration | May 7, 2019 | — |
| S-8 | Employee stock plan registration | Jul 13, 2018 | — |
| 424B4 | Prospectus | Jun 15, 2018 | — |
| S-1/A | Amended registration statement | Jun 5, 2018 | — |
| S-1 | Registration statement | May 22, 2018 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VRCA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Chester, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1660334
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.